5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer

NCT01216644 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

716

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: 5-Fluorouracil
DRUG: Leucovorin
DRUG: Oxaliplatin
DRUG: Docetaxel
DRUG: Epirubicin
DRUG: Cisplatin
DRUG: 5-fluorouracil

Sponsor

Krankenhaus Nordwest